Phase I study of CC-486 alone and in combination with carboplatin or nab-paclitaxel in patients with relapsed or refractory solid tumors

  1. Von Hoff, D.D.
  2. Rasco, D.W.
  3. Heath, E.I.
  4. Munster, P.N.
  5. Schellens, J.H.M.
  6. Isambert, N.
  7. Le Tourneau, C.
  8. O'Neil, B.
  9. Mathijssen, R.H.J.
  10. Lopez-Martin, J.A.
  11. Jeff Edenfield, W.
  12. Martin, M.
  13. LoRusso, P.M.
  14. Bray, G.L.
  15. DiMartino, J.
  16. Nguyen, A.
  17. Liu, K.
  18. Laille, E.
  19. Bendell, J.C.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2018

Alea: 24

Zenbakia: 17

Orrialdeak: 4072-4080

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-17-3716 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus